Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Walter Newman"'
Autor:
Charles Caldwell, James B. Rottman, Will Paces, Elizabeth Bueche, Sofia Reitsma, Joseph Gibb, Vitria Adisetiyo, Michael S. Haas, Heidi Heath, Walter Newman, Jason Baum, Roberto Gianani, Michael H. Kagey
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Dickkopf-1 (DKK1) is a secreted modulator of Wnt signaling that is frequently overexpressed in tumors and associated with poor clinical outcomes. DKN-01 is a humanized monoclonal therapeutic antibody that binds DKK1 with high affinity and ha
Externí odkaz:
https://doaj.org/article/386bfb9934384f32ac9a8bd2228acb37
Autor:
Edward J. Jarman, Marta Horcas‐Lopez, Scott H. Waddell, Stephanie MacMaster, Konstantinos Gournopanos, Daniel Y. H. Soong, Kamila I. Musialik, Panagiota Tsokkou, Minn‐E Ng, William A. Cambridge, David H. Wilson, Michael H. Kagey, Walter Newman, Jeffrey W. Pollard, Luke Boulter
Publikováno v:
Jarman, E, Horcas Lopez, M, Waddell, S, MacMaster, S, Gournopanos, K, Soong, D, I. Musialik, K, Tsokkou, P, Ng, M-E, Cambridge, W, Wilson, D, Kagey, M H, Newman, W, Pollard, J W & Boulter, L 2022, ' DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01 ', Liver International . https://doi.org/10.1111/liv.15383
Background and aims: Dickkopf-1 (DKK1) is associated with poor prognosis in intrahepatic cholangiocarcinoma (iCCA), but the mechanisms behind this are unclear. Here, we show that DKK1 plays an immune regulatory role in vivo and inhibition reduces tum
Autor:
Walter Newman, James B. Rottman, Franziska Schuerpf, Heidi Heath, Michael H. Kagey, Michael S. Haas
Flow Cytometry Gating Strategy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83f5dcc61b20a2fcad95448da894c3a8
https://doi.org/10.1158/1541-7786.22526999.v1
https://doi.org/10.1158/1541-7786.22526999.v1
Autor:
Walter Newman, James B. Rottman, Franziska Schuerpf, Heidi Heath, Michael H. Kagey, Michael S. Haas
Dickkopf-1 (DKK1), a secreted modulator of Wnt signaling, is overexpressed in many cancers, is often associated with worse clinical outcomes, and has been shown to have immunosuppressive effects. DKN-01 is an IgG4 clinical stage antibody that potentl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a770e7b3842bd86663344e6274479bf
https://doi.org/10.1158/1541-7786.c.6545285.v1
https://doi.org/10.1158/1541-7786.c.6545285.v1
Autor:
Walter Newman, James B. Rottman, Franziska Schuerpf, Heidi Heath, Michael H. Kagey, Michael S. Haas
mDKN-01 has Additive Activity with an Anti-PD-1 Antibody
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8268e99cc05723647b3b14ef9eaaafb1
https://doi.org/10.1158/1541-7786.22526996
https://doi.org/10.1158/1541-7786.22526996
Autor:
Jason J. Luke, Jedd D. Wolchok, Taha Merghoub, Cynthia A. Sirard, Diane Piper, Lianna Sifferlen, Phillip Wong, Aliya Holland, Jingjing Qi, Walter Newman, Olivier Rixe, David Bajor, Todd Bauer, Takami Sato, Girish S. Naik, Hong Wang, Roberta Zappasodi, Diwakar Davar
Supplementary Table from Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06e8274a662db94b0372cb7e7542e809
https://doi.org/10.1158/1078-0432.22486856
https://doi.org/10.1158/1078-0432.22486856
Autor:
Jason J. Luke, Jedd D. Wolchok, Taha Merghoub, Cynthia A. Sirard, Diane Piper, Lianna Sifferlen, Phillip Wong, Aliya Holland, Jingjing Qi, Walter Newman, Olivier Rixe, David Bajor, Todd Bauer, Takami Sato, Girish S. Naik, Hong Wang, Roberta Zappasodi, Diwakar Davar
Purpose:TRX518 is a mAb engaging the glucocorticoid-induced TNF receptor−related protein (GITR). This open-label, phase I study (TRX518-003) evaluated the safety and efficacy of repeated dose TRX518 monotherapy and in combination with gemcitabine,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d505d5d9e72ee2c945357f5aef741ec3
https://doi.org/10.1158/1078-0432.c.6532406.v1
https://doi.org/10.1158/1078-0432.c.6532406.v1
Autor:
Jason J. Luke, Jedd D. Wolchok, Taha Merghoub, Cynthia A. Sirard, Diane Piper, Lianna Sifferlen, Phillip Wong, Aliya Holland, Jingjing Qi, Walter Newman, Olivier Rixe, David Bajor, Todd Bauer, Takami Sato, Girish S. Naik, Hong Wang, Roberta Zappasodi, Diwakar Davar
Supplementary Data from Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b804d37d72c5b64ee02158bbc8605da
https://doi.org/10.1158/1078-0432.22486880
https://doi.org/10.1158/1078-0432.22486880
Autor:
Jason J. Luke, Jedd D. Wolchok, Taha Merghoub, Cynthia A. Sirard, Diane Piper, Lianna Sifferlen, Phillip Wong, Aliya Holland, Jingjing Qi, Walter Newman, Olivier Rixe, David Bajor, Todd Bauer, Takami Sato, Girish S. Naik, Hong Wang, Roberta Zappasodi, Diwakar Davar
Supplementary Figure from Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3addefab290e824d920fb0999caa57c8
https://doi.org/10.1158/1078-0432.22486877
https://doi.org/10.1158/1078-0432.22486877
Autor:
Heidi Heath, Michael Haas, Michael H. Kagey, Walter Newman, James B. Rottman, Franziska Schuerpf
Publikováno v:
Molecular Cancer Research. 19:717-725
Dickkopf-1 (DKK1), a secreted modulator of Wnt signaling, is overexpressed in many cancers, is often associated with worse clinical outcomes, and has been shown to have immunosuppressive effects. DKN-01 is an IgG4 clinical stage antibody that potentl